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John-Paul Carpenter1†, Amit R Patel2† and Juliano Lara Fernandes3*†Abstract
The 16th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR) took place in
San Francisco, USA at the end of January 2013. With a faculty of experts from across the world, this congress
provided a wealth of insight into cutting-edge research and technological development. This review article
intends to provide a highlight of what represented the most significant advances in the field of cardiovascular
magnetic resonance (CMR) during this year’s meeting.
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This year’s SCMR Annual Scientific Sessions were attended
by a record number of 1427participants. The number of
abstracts presented during the meeting also grew signifi-
cantly from previous editions with a total of 602 abstracts
being shown. Many of these new abstracts were intro-
duced during the SCMR/International Society for Mag-
netic Resonance in Medicine (ISMRM) Jointly Sponsored
Workshop “New Horizons in High-field Cardiovascular
Imaging: Promises and Progress” as well as in the new
ePosterGallery.
In this article, we have tried to cover most of the themes
presented during the five days of the event summarizing
the topics into technical/imaging methods and clinical ap-
plications. Throughout the meeting, the SCMR Program
Committee ensured that all of the major areas of interest
were covered with an invited lecture session to complement
the scientific abstract presentations. All abstracts presented
during the meeting can be accessed in the special supple-
ment of the Journal of Cardiovascular Magnetic Resonance
[1]. Many of the invited lectures and oral abstract sessions
were recorded and are available at www.scmr.org.
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reproduction in any medium, provided the orStefan Neubauer), the best oral presentations and abstract
award winners for both SCMR annual scientific sessions
and the SCMR/ISMRM workshop are given in Tables 1
and 2. The winning authors of the Gerald Pohost award
for best Journal of Cardiovascular Magnetic Resonance
(JCMR) manuscript in 2012 are shown in Table 3.Technical advances/imaging methods
This year’s SCMR/ISMRM pre-Sessions workshop focused
on the development of high-field CMR, an increasing area
of interest as scanners move from 1.5 T to 3.0 T and even
7.0 T systems [5,6]. Challenging problems with high field
strengths currently involve the development of specific
transmit/receive coils to allow assessment of 23Na-MRI as
well as CMR-spectroscopy, new imaging sequences to take
advantage of the increase in signal-to-noise ratio (SNR) as
well as better ways to handle ECG gating. In that regard,
Ferreira et al. presented a new free-breathing navigator se-
quence to assess cardiac diffusion tensor imaging (DTI) at
3 T to characterize myocardial fiber disarray patterns as
has recently been published [7-9] while Teh et al. demon-
strated a new accelerated diffusion-weighted fast spin echo
sequence that resulted in an 8-fold increase in acquisi-
tion time in a mouse model using 9.4 T scanning [10].
DTI was the subject of one of three plenary lectures
delivered by Dudley Pennell at the opening of the main
meeting (http://scmr.org/Education/CMR-online-video-
on-demand-lectures/3072/3248/3252.html) – Figure 1.
As mentioned above, ECG gating becomes more difficult
with increasing field strength due to magnetohydrodynamicral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 16th SCMR annual scientific sessions – awards
Award Recipient Institution Subject
SCMR Gold Medal Professor Stefan
Neubauer
Oxford University For outstanding contribution to the field of CMR
Early career award – basic science Behzad Sharif Cedars-Sinai Medical Center Eliminating dark-rim artifacts in first-pass myocardial
perfusion imaging (O3)
Early career award – translational James Harrison King’sCollege London Magnetic resonance imaging of acute and chronic atrial
ablation injury – a histological validation study (O18)
Early career award – clinical Saira Dass The John Radcliffe Hospital Patients with dilated cardiomyopathy (DCM) have
appropriate myocardial oxygenation response to
vasodilator stress (O68)
Moderated poster session 1 Kathryn Broadhouse Imperial College London Quantification of aortic pulse wave velocity in preterm
infants using 4D phase contrast MRI (M7)
Moderated postersession 2 Daniel Kuetting Universityof Bonn Assessment of cardiac dyssynchrony: a comparison of velocity
encoded imaging and feature tracking analysis (M11)
Best technologist abstract Celia O’Meara UniversityCollege London
Hospitals
Initial experience of imaging cardiac sarcoidosis using
hybrid PET-MR – a technologist’s case study (T1)
Best SCMR web case of the year Rob Huggett Russells Hall Hospital, UK Post pericardiectomy for constriction – a late complication
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problem, Krug et al. demonstrated the problems encoun-
tered with regular vectorcardiograms at 3.0 and 7.0 T pro-
posing an independent component analysis alternative [11]
and Tse et al. presented a new 3D-QRS method using 12-
lead ECG gating inside the magnet to allow for real-time
gating at 3.0 T in patients with complex heart rates such as
premature ventricular beats, atrial fibrillation and significant
beat-to-beat variations [12].
Increasing spatial/temporal resolution
Many advances presented this year dealt with technical
developments with the objective of increasing the spatial
and/or temporal resolution of CMR images as well as
decreasing image acquisition time. One major focus was
how to implement new methods in order to acquire
real-time non triggered images allowing much more
simple and robust imaging as well as permitting the use
of CMR to guide percutaneous interventions [13]. Aneja
et al. demonstrated that real-time CMR using non-
optimized sequences with lower spatial and temporal
resolution already derives similar results to traditional
breath-held images in patients with regular cardiac rhythm
[14]. Although this approach was limited to a small num-
ber of patients and using standard sequences only, the
principles of real-time imaging are rapidly gaining accept-
ance as CMR increases its clinical utility.Table 2 SCMR/ISMRM workshop abstract awards
Award Recipient Institution
Best Oral Abstract Gabriel Camargo Clinica de Diagnostico por Im
Rio de Janeiro, Brazil
Best Poster Johannes Krug Otto-von-Guericke University
MagdeburgWith that objective in mind, an increasing number of ab-
stracts focused on new sequences that take advantage of
undersampling the k-space with spatiotemporal modeling
such as compressed sensing [15] to increase current reso-
lution limits. Using sparse and incoherent sampling with
multiple iterative reconstructions Schmidt et al. showed
that these new techniques provide high spatial (2.4 × 1.7 ×
6.0 mm) as well as temporal resolution (33 ms) within 1
heartbeat acquisition in real time [16]. Introducing a new
regional sparsity reconstruction method, Chen et al. also
demonstrated the feasibility of compressed sensing for
obtaining in vivo perfusion images, allowing for increase in
ventricular coverage or spatial resolution as previous tech-
niques have shown [17,18].
Non-cartesian acquisitions have also seen a gain in use
and moved from the preliminary work in coronary artery
imaging to other applications in CMR [19]. Sharif et al.
used an ungated radial acquisition method to acquire
first-pass perfusion images simultaneously combined
with cine images for assessment of perfusion and wall
motion within the same scan [20]. Yang et al. also used a
combination of spiral trajectories with compressed sens-
ing to obtain full ventricular coverage during first pass
perfusion with the acquisition of 8 slices in 480 ms with
1.75 × 1.75 mm in-plane resolution allowing for heart
rates up to 125 beats per minute during stress imaging
[21]. In another abstract by Petersson et al. the authorsManuscript title
agem, Myocardial Iron Quantification Using Modified Look-Locker
Inversion Recovery (MOLLI) T1 Mapping at 3 Tesla
of Improved ECG Based Gating in Ultra High Field Cardiac MRI
Using an Independent Component Analysis Approach
Table 3 Gerald Pohost award for best Journal of Cardiovascular Magnetic Resonance (JCMR) manuscript in 2012
Award Recipient Institution Manuscript title
First place Jurg Schwitter University Hospital,
Lausanne
Superior diagnostic performance of perfusion-cardiovascular magnetic resonance
versus SPECT to detect coronary artery disease: The secondary endpoints of the
multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for
Myocardial Perfusion Assessment in Coronary Artery Disease Trial). [2]
Second place Peter Kellman National Institutes of
Health (NIH)
Extracellular volume fraction mapping in the myocardium, part 1: evaluation of
an automated method. [3]
Third place Choukri Mekkaoui Harvard Medical
School
Fiber architecture in remodeled myocardium revealed with a quantitative diffusion
CMR tractography framework and histological validation. [4]
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quire 4D flow stacks with a significant 62% reduction in
scan time while maintaining similar image quality com-
pared to traditional readout methods [22].
Improving artifacts
Another highlight of the meeting was in the develop-
ments of new methods to overcome old problems in
CMR such as dark rim artifacts, off-resonance effects and
banding [23]. The Early Career Award in Basic Sciences
was awarded to Sharif et al. for an abstract that proposed
to reduce dark-rim artifacts during first-pass perfusion
by using a single-shot radial sequence in comparison to
the routine Cartesian technique with a significant de-
crease in both artifact score as well as in its maximum
width (Figure 2) [24]. Problems with 3 T MRI were also
addressed by Wu et al. who proposed a shorter TR for
SSFP cine imaging through a reduced RF pulse duration
and readout showing that the new approach resulted in
images more robust to field in homogeneity at this higher
field strength with minimum reduction in spatial reso-
lution while allowing for elimination of frequency scouts
and more rapid breath-hold times [25]. Another way to
improve susceptibility artifacts without the need to use
time consuming frequency adjustments was presented by
Rothstein et al. who proposed a new 3D shimming algo-
rithm which resulted in similar results for volumes andFigure 1 Diffusion tensor imaging in the basal short-axis plane in a p
diffusion-weighted stimulated-echo single-shot echo-planar-imaging seque
which follows the orientation of the myocytes, is represented by cylindrica
green circumferential, red left-handed (Image courtesy of Pedro Ferreira anfunction evaluation keeping the same levels of banding
artifacts as frequency offsets but with a more simplified
workflow [26].
T1 Mapping sequence developments
With the rapidly increasing body of new clinical data on
T1 mapping, more understanding of the fundamental
principles of the sequences used to generate these maps
is essential [27]. A comprehensive series of lectures on
T1 mapping in the heart was presented by Peter Kellman,
Martin Ugander, Erica Dall’ Armellina and Andrew Flett
(http://scmr.org/Education/CMR-online-video-on-demand-
lectures/3072/3151/3154.html).This provided a clear ex-
planation of the pros and cons of each of the different
sequences together with the importance of both accuracy
and precision of measurement. The potential clinical ap-
plications of T1 mapping including the measurement of
extracellular volume fraction to visualize the extent and
severity of abnormalities within the myocardium were
outlined in detail.
Almost 10% of the submitted abstracts for the meeting
involved T1 mapping. Many sessions discussed the current
use of T1 maps and the need to standardize and optimize
the acquisition techniques to pre- and post-contrast maps,
the use of bolus versus continuous infusion of gadolinium
as well as the different approaches to heart rate variability
and types of sequences. Fitts et al. presented a recentatient with hypertrophic cardiomyopathy. The acquisition used a
nce during multiple breath holds. The tensor’s main eigenvector,
l glyphs, colour coded according to the helix angle: blue right-handed,
d Dudley Pennell).
Figure 2 Elimination of dark rim artifact on first-pass perfusion imaging using radial k-space trajectory. The left hand panel shows
examples of first pass perfusion images in two subjects. The artifact seen in the phase encode (PE) direction with Cartesian trajectory (top row) is
eliminated with radial k-space filling (bottom row). The histograms reveal a significant reduction in artifact scores (on a scale of 1–4) and
maximum width of dark rim artifacts (DRA) with the radial technique (Sharif et al., abstract O3).
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overcome some of the limitations of the most widely used
modified Look-Locker inversion recovery (MOLLI) tech-
niques [28]. The sequence is based on saturation recov-
ery magnetization and uses centric k-space ordering
resulting in smaller coefficients of variation and higher
T1 values in patients with high heart rates or arrhyth-
mias. In another study using phantoms, Slavin et al. also
showed that using a saturation recovery pulse but with a
balanced SSFP readout they could find more accurate T1
values compared to MOLLI due to its insensitivity to
beat-to-beat variations and lack of T2 dependence [29].
In a comparison of different sequences including the
classical MOLLI sequence, a shortened (sh)MOLLI acqui-
sition with 9 heartbeats [30], a 3′5 MOLLI and a saturation
recovery single shot acquisition sequence (SASHA) the au-
thors reported that the 3′5 MOLLI sequence was more
closely associated to the original MOLLI T1 values com-
pared to the two other sequences while the shMOLLI tech-
nique underestimated T1 values by 13% and the SASHA
sequence overestimated the T1 values by 17%. Finally, a 3D
technique acquired with free breathing was also presented
by Henningsson et al. with the average scan time of
9:37 minutes to cover the whole left ventricle with a reso-
lution of 1.5 × 1.5 × 8 mm3 using SASHA resulting in an
increase in SNR compared to 2D-SASHA images with
similar T1 values [31].
Developments in vascular imaging
The development of rapid prototyping (or 3D printing)
has allowed highly accurate models of vascular struc-
tures to be generated [32]. Acevedo-Bolton et al. de-
scribed how complex intracranial aneurysms imaged
with magnetic resonance could be recreated in order to
test the effectiveness of flow-diverting stents [33]. Thiswork not only enables the operator to gain valuable ex-
perience on a ‘dry run’ but allows assessment of the pre-
and post-procedure flow dynamics using 4D flow.
Three other oral presentations described the utility of
the quiescent-interval single shot or ‘QISS’ sequence for
non-contrast MR angiography. The technique (with
various alterations including radial vs. Cartesian geom-
etry k-space acquisition) shows excellent performance
and correlates very well with contrast exams in patients
with peripheral arterial disease. These angiographic tech-
niques have the potential to be combined with more func-
tional assessment (such as rest and stress calf perfusion) to
assess ischemia and response to treatment [34]. Clement-
Guinaudeauet al presented data on a calf muscle perfusion
index which correlated very well with peak walking time
and claudication onset time [35]. Using a simple MR-
compatible device to allow exercise stress in the scanner
bore, this has useful potential as a surrogate endpoint for
clinical trials.
Implementation of CMR into routine clinical
practice
In addition to many technical developments, this year’s
SCMR also featured several presentations showing the
central role of CMR in the management of the cardio-
vascular patient. One of the strengths of this year’s con-
ference was the introductory talk given by an expert in
the field at the start of each of the oral abstract sessions.
Raymond Kwong succinctly summarized the available
evidence from the last 25 years on how the development
of CMR has helped diagnosis, determine prognosis and
provide an impact on diagnostic thinking, therapeutic
actions and patient outcomes. Anya Wagner presented
the most recent results of the EuroCMR registry cover-
ing 27,000 patients from 57 European centers [36]. This
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in Europe, proving that it is feasible and safe with 62% of
the scans performed having an impact on patient manage-
ment, the most common indication being for risk stratifi-
cation in coronary artery disease. Florian Andre presented
data from a cohort of more than a 1000 patients showing
that measuring left ventricular ejection fraction by CMR
reclassified many patients into different risk groups when
compared to echocardiography [37]. Others have shown
the potential clinical impact of more accurate measure-
ment of ejection fraction by CMR on selecting patients
who might benefit from defibrillator implantation [38].
Recently, it has been demonstrated that the addition of
late gadolinium enhancement CMR adds further prog-
nostic value over echocardiography alone [39]. Addition-
ally, it is becoming increasingly recognized that using
CMR in a cost-effective way can provide potential savings
for healthcare providers [40].
Ischemic heart disease
With the publication of CE-MARC [41] and MR-
IMPACT 2 [2] vasodilator stress CMR has been shown
in prospectively designed studies to be a reasonable al-
ternative to stress single-photon emission computed
tomography (SPECT) for the detection of significant
coronary artery disease. It has additionally been shown
that performing stress CMR to identify patients who
benefit from coronary angiography offers significant
savings when compared to directly performing coronary
angiography. John Greenwood adds to this by presenting
new data from the CE-MARC trial suggesting that strat-
egies the utilize stress CMR first followed by invasive cor-
onary angiography if the CMR study is abnormal or
inconclusive may be more cost-effective when comparedFigure 3 3D CMR perfusion scan during adenosine infusion showing
walls extending from the base to the apex. Invasive coronary angiograp
artery (Manka et al., abstract O103).to a SPECT first strategy [42]. Similarly, Sebastian Kelle
showed the cost-effectiveness of strategies for the as-
sessment of stable coronary artery disease that utilize
dobutamine stress to identify patients who might benefit
from a coronary angiogram rather than sending all patients
directly to cardiac catheterization [43]. Using a Markov
analysis, Steffen Petersen presented data suggesting that the
cost-effectiveness of a diagnostic strategy was dependent
on the pretest probability of having coronary artery disease.
His analysis suggested stress CMR strategies were most
cost effective in patients with a higher pretest probability
and that cardiac computed tomography strategies were
more cost-effective in patients with a low to intermediate
pretest probability [44].
An important limitation of stress CMR is the incomplete
coverage of the left ventricle and may prevent adequate as-
sessment of ischemic burden. Sven Plein compared the
ischemic and scar burden as determined by a standard
clinical stress CMR technique to SPECT [45]. He found
that CMR measures significantly less scar but more ische-
mia than SPECT possibly due to the incomplete cover-
age of perfusion CMR. In a prospective, multicenter trial,
Robert Manka showed that whole heart, three-dimensional
myocardial perfusion imaging (Figure 3) correlated highly
with fractional flow reserve [46].It remains to be seen
whether such a technique will improve the quantification
of ischemic burden and whether the burden of ischemia as
measured by CMR can identify patients who will benefit
from revascularization in addition to aggressive medical
therapy alone.
Non-ischemic heart disease
The role of CMR in the assessment and risk stratifica-
tion of non-ischemic heart disease is well establishedan inducible perfusion defect in the anterior and anteroseptal
hy identified a high-grade stenosis in the left anterior descending
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to risk stratify patients with a variety of non-ischemic
heart diseases such as dilated cardiomyopathy, myocar-
dial siderosis, and hypertrophic cardiomyopathy (HCM)
[48]. However, large outcome studies remain challen-
ging. Ismail et al. presented data on 711 consecutive pa-
tients with HCM with a total of 2852 patient-years of
follow-up [49]. Although the amount of fibrosis was a
significant univariate predictor of sudden cardiac death
risk, on multivariate analysis, only left ventricular ejec-
tion fraction remained a significant predictor. The un-
derstanding of the HCM phenotype is becoming ever
more complex [48,50]. Deva explained the incremental
predictive value of inferoseptal crypts [51] and Flett pro-
posed a previously unrecognized pattern of relative ap-
ical hypertrophy which may be an early form of HCM as
the group found many features of HCM in patients with
unexplained T-wave inversion [52]. Christopher Kramer
unveiled the details of a proposed large scale, multi-
parametric, multicenter, observational registry with the
goal of better defining the role of CMR in the risk strati-
fication of the HCM patient.
As previously mentioned, T1 mapping featured highly
throughout the sessions. Sado et al. presented findings
of low pre-contrast T1 values in Anderson-Fabry disease
and iron overload which may help to define pre-clinical
phenotypes more accurately [53]. Whereas the assess-
ment of diastolic function has traditionally been cumber-
some and time-consuming with CMR, Simpson et al.
have developed a new high spatial and temporal resolution
tissue phase contrast technique which allows much shorter
acquisitions and brings this nearer to clinical prime-time
[54]. In an invited lecture, Michael Markl reviewed promis-
ing techniques such as tissue phase mapping with respira-
tory navigator gating, 2-dimensional and 3-dimensional
Displacement Encoding with Stimulated Echoes (DENSE),
and strain encoded imaging (SENC) for assessing myocar-
dial mechanics and quantifying the various components of
myocardial strain (http://scmr.org/Education/CMR-online-
video-on-demand-lectures/3072/3157/3160.html). During
the same session, Alicia Maceira, Amit Patel, and Sophie
Mavrogeni suggested that CMR with late gadolinium en-
hancement imaging plays an important role for the detec-
tion of cardiac involvement and risk stratification of
patients with systemic disorders such as amyloidosis, vas-
culitis, and other rheumatologic disorders such as systemic




Francisco Leyva reviewed the role of CMR for identifying
patients that may benefit from defibrillator implantation
and resynchronization therapy (http://scmr.org/Education/CMR-online-video-on-demand-lectures/3072/3163/3164.
html). Several investigators have shown that the extent of
late gadolinium enhancement is strongly associated with
need for future ICD therapy [55]. The burden of late gado-
linium enhancement is also associated with likelihood of
responding to resynchronization therapy; in fact, using late
gadolinium enhancement images to guide left ventricular
lead placement improves outcomes following biventricular
pacing [56].
The continued development of real-time imaging for
interventional CMR procedures is an important area of
research. Tse et al presented preliminary animal data on
a voltage-based electroanatomic tracking system which
can be used to measure intracardiac electrograms both in
and out of the scanner bore, including during imaging se-
quences. Radiofrequency signals from patches on the skin
allow the operator to track the navigation of a catheter
tip without the need for co-registration [57]. Ramanan
et al. went on to describe how catheter ablation lesions
could be mapped acutely using a combination of T2 and
T1* mapping with late gadolinium enhancement [58].
This has the potential for verifying the effectiveness of
ablation by differentiating the actual lesion area from sur-
rounding oedema. On a different subject, Ainslie et al.
reported interim data from the multiparametric CMR
assessment on RV apical versus septal pacing study
(MAPS)which aims to determine the optimal site for
right ventricular pacing using CMR, echo, cardiopulmo-
nary exercise testing and biomarkers [59]. Patients with
persistent atrial fibrillation requiring AV node ablation
and permanent pacemaker implants were fitted with an
MR-conditional St. Jude pacemaker and two RV endocar-
dial leads placed at the RV apex and in the septum (one
in the ventricular port and one in the atrial port of the
device). Using a crossover study design with ventricular
pacing at each of the sites, CMR measurements were
taken at three time points. Early results have shown that
not only is cardiac scanning safe in these patients but
that there is higher aortic and pulmonary flow as well as
less dyssynchrony with septal pacing.
Congenital heart disease
CMR continues to show its superiority over other im-
aging modalities in the field of congenital cardiovascular
disease. This year cases for one of the congenital heart
case review sessions were competitively selected from
open competition with blind and independent ratings
from several expert reviewers. The resultant session was
popular, interactive and of high quality. The benefits of
CMR in congenital heart disease, not least with regards
accurate anatomical delineation, were well illustrated. In
addition, refinements in flow imaging are improving our
understanding not only in complex congenital disease
but also in more routine cases. Muzzarelli et al. presented
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bicuspid aortic valve disease [60] and Hart et al. demon-
strated how 4D flow can give a much greater insight into
the understanding of haemodynamics of the Fontan cir-
culation during the breathing cycle [61]. Although acqui-
sitions can be long and complex post-processing is
required, 4D flow techniques have the potential to de-
velop into a useful clinical tool [62].
Case presentations
As in previous years, a highly popular component of the
program involved a series of 10 case review sessions, each
discussing a range of interesting cases including complex,
challenging problems and more mundane day-to-day cases.
A lively, interactive debate was generated between dele-
gates and experts in the field. The SCMR website publishes
a regular featured ‘case of the week’ and the best 5 of these
cases from 2012 were presented in full (http://scmr.org/
caseoftheweek.html).
Conclusions
In conclusion, the 2013 SCMR Scientific Sessions has con-
solidated a now long track record of successful meetings
positioning CMR as a robust and prominent option in car-
diovascular imaging. The technical advances highlighted
here and the clinical applications ready to be implemented
in daily routine presented at the meeting demonstrate that
the method has never been so relevant and promising, with
a continuous increase in the number of manuscripts pub-
lished as well as a rising number of practitioners. SCMR
deserves much recognition for this accomplishment and its
meeting is certainly a reflection of that success.
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